Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Speciallægeselskabet Groblos ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   13.2% 6.6% 3.3% 5.6% 2.9% 1.7% 5.9% 5.9%   Credit score (0-100)   18 36 53 40 57 72 39 39   Credit rating   BB BBB BBB BBB BBB A BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   155 0 0 0 0 0 0 0   Gross profit   145 190 227 266 377 4,142 0.0 0.0   EBITDA   145 190 227 266 360 2,247 0.0 0.0   EBIT   145 190 227 266 360 1,402 0.0 0.0   Pre-tax profit (PTP)   144.8 589.1 585.1 20.6 647.1 1,337.4 0.0 0.0   Net earnings   112.8 459.3 485.6 36.6 534.2 1,050.8 0.0 0.0   Pre-tax profit without non-rec. items   145 589 585 20.6 647 1,337 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 6,563 0.0 0.0   Shareholders equity total   113 572 987 1,024 1,269 2,199 2,024 2,024   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 8,039 614 614   Balance sheet total (assets)   122 718 1,116 1,126 1,467 11,103 2,638 2,638   Net Debt   -113 -657 -1,035 -956 -1,387 7,118 614 614     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   155 0 0 0 0 0 0 0   Net sales growth   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   145 190 227 266 377 4,142 0.0 0.0   Gross profit growth   0.0% 31.1% 19.7% 17.1% 41.7% 998.8% -100.0% 0.0%   Employees   0 0 0 0 0 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   122 718 1,116 1,126 1,467 11,103 2,638 2,638   Balance sheet change%   0.0% 486.9% 55.4% 0.9% 30.3% 656.7% -76.2% 0.0%   Added value   144.8 189.8 227.2 266.1 360.3 2,247.4 0.0 0.0   Added value %   93.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 8,357 -6,563 0   Net sales trend   0.0 -1.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   93.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   93.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 95.6% 33.9% 0.0% 0.0%   Net Earnings %   72.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   72.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   93.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   118.4% 140.2% 63.8% 33.5% 35.3% 24.7% 0.0% 0.0%   ROI %   128.4% 172.0% 75.1% 37.4% 39.9% 26.8% 0.0% 0.0%   ROE %   100.0% 134.1% 62.3% 3.6% 46.6% 60.6% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   92.2% 79.7% 88.5% 90.9% 86.5% 19.8% 76.7% 76.7%   Relative indebtedness %   6.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   -66.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -78.0% -346.2% -455.4% -359.2% -384.9% 316.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 365.5% 30.3% 30.3%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 5.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   12.8 4.5 8.1 10.2 7.0 2.3 0.0 0.0   Current Ratio   12.8 4.5 8.1 10.2 7.0 2.3 0.0 0.0   Cash and cash equivalent   112.9 657.3 1,034.6 955.7 1,386.7 920.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   78.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   112.8 -138.0 -127.5 264.1 12.4 1,016.6 -306.9 -306.9   Net working capital %   72.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 749 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 749 0 0   EBIT / employee   0 0 0 0 0 467 0 0   Net earnings / employee   0 0 0 0 0 350 0 0